BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
674 results:

  • 1. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
    Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrative multi-omics characterization reveals sex differences in glioblastoma.
    Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
    Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experiments.
    Ge W; Yuan G; Wang D; Dong L
    Sci Rep; 2024 Feb; 14(1):3783. PubMed ID: 38360888
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
    PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Artificial Intelligence Imaging for Predicting High-risk Molecular Markers of Gliomas.
    Liang Q; Jing H; Shao Y; Wang Y; Zhang H
    Clin Neuroradiol; 2024 Mar; 34(1):33-43. PubMed ID: 38277059
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma.
    Shaikh MAJ; Altamimi ASA; Afzal M; Gupta G; Singla N; Gilhotra R; Almalki WH; Kazmi I; Alzarea SI; Prasher P; Singh SK; Dua K
    Pathol Res Pract; 2024 Feb; 254():155121. PubMed ID: 38262269
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. germline USP36 Mutation Confers Resistance to egfr-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small cell Lung Cancer.
    Guan S; Chen X; Wei Y; Wang F; Xie W; Chen Y; Liang H; Zhu X; Yang Y; Fang W; Huang Y; Zhao H; Zhang X; Liu S; Zhuang W; Huang M; Wang X; Zhang L
    Clin Cancer Res; 2024 Apr; 30(7):1382-1396. PubMed ID: 38261467
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. nSEA: n-Node Subnetwork Enumeration Algorithm Identifies Lower Grade Glioma Subtypes with Altered Subnetworks and Distinct Prognostics.
    Zhang Z; Wang C; Zhao Z; Yi Z; Durmaz A; Yu JS; Bebek G
    Pac Symp Biocomput; 2024; 29():521-533. PubMed ID: 38160304
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A network pharmacology- and transcriptomics-based investigation reveals an inhibitory role of β-sitosterol in glioma via the egfr/MAPK signaling pathway.
    Xie Y; Chen Z; Li S; Yan M; He W; Li L; Si J; Wang Y; Li X; Ma K
    Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):223-238. PubMed ID: 38143380
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of tumor-Resident Adaptive Immune Receptor Recombinations.
    Dabkowski TR; Varkhedi M; Song JJ; Gozlan EC; Blanck G
    JCO Precis Oncol; 2023 Sep; 7():e2300057. PubMed ID: 38085056
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma.
    Chen Y; Mu Y; Guan Q; Li C; Zhang Y; Xu Y; Zhou C; Guo Y; Ma Y; Zhao M; Ji G; Liu P; Sun D; Sun H; Wu N; Jin Y
    Cell Death Dis; 2023 Nov; 14(11):757. PubMed ID: 37985768
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience.
    Molica C; Gili A; Nardelli C; Pierini T; Arniani S; Beacci D; Mavridou E; Mandarano M; Corinaldesi R; Metro G; Gorello P; Giovenali P; Cenci N; Castrioto C; Lupattelli M; Roila F; Mecucci C; La Starza R
    Sci Rep; 2023 Nov; 13(1):20101. PubMed ID: 37973912
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KIF22 promotes the proliferation and glycolysis of melanoma by activating egfr/STAT3 signaling.
    Zhong Z; Zhong H
    Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy.
    Luo Q; Zhuang J; Zheng D; Miao C; Luo H; Peng J; Zheng C; Qin C; Lan C; Chen M; Xia Y; Huang D; Chen Z
    Front Immunol; 2023; 14():1282734. PubMed ID: 37928523
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparative Analysis of the Prognostic Significance of IDH,TERT, egfr and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study.
    Alimohamadi M; Larijani A; Pour-Rashidi A; Farzin M; Ebrahimi H; Rahmani M; Hendi K; Yarandi KK; Aghajanian S; Shirani M
    World Neurosurg; 2024 Jan; 181():e628-e639. PubMed ID: 37914076
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Exploring the association of glioma tumor residuals from incongruent [
    Li X; Cheng Y; Han X; Cui B; Li J; Yang H; Xu G; Lin Q; Xiao X; Tang J; Lu J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):779-796. PubMed ID: 37864593
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
    Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epigenomic perturbation of novel egfr enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide.
    Vincent CA; Nissen I; Dakhel S; Hörnblad A; Remeseiro S
    BMC Cancer; 2023 Oct; 23(1):945. PubMed ID: 37803333
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
    Furuta T; Negoto T; Miyoshi H; Moritsubo M; Nakamura H; Morioka M; Akiba J; Ohshima K; Sugita Y
    J Neurooncol; 2023 Sep; 164(3):633-641. PubMed ID: 37710025
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
    Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
    J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 34.